NovaBay Pharmaceuticals (NBY) Q4 2025 Earnings

7NovConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-1.15
-0.84
-0.52
-0.21

Details

Expected EPS
-1.05
Actual EPS
-1.15
Surprise EPS
-0.1
Surprise Percent
+9.52%

Description

NovaBay Pharmaceuticals (NBY) has reported earnings of -1.15 per share for Q4 2025.

0 Comments

Share your thoughts